Source-grounded facts extracted from BRUKER CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
BRUKER CORP reported FY2026 results: revenue $3.57 to $3.60 billion, EPS $2.10 to $2.15. Guidance reaffirmed.
“Reconfirming previous FY2026 guidance: o Revenues of $3.57 to $3.60 billion, up 4% to 5% yoy, with organic growth of 1% to 2% o Non-GAAP EPS of $2.10 to $2.15, up 15% to 17% yoy, including an ~8% FX headwind”
BRUKER CORP reported the three months ended March 31, 2026 results: revenue $823.4 million, EPS $0.02.
“Bruker Reports First Quarter 2026 Financial Results • Q1 2026 revenues of $823.4 million, up 2.7% year-over-year (yoy), down 4.4% organically • Q1-26 GAAP diluted earnings per share (EPS) $0.02; non-GAAP diluted EPS $0.31”
BRUKER CORP: Filed Certificate of Designations to establish terms of 6.375% Mandatory Convertible Preferred Stock, Series A (effective 2025-09-08).
“the Company filed a Certificate of Designations (the “Certificate of Designations”) with the Secretary of State of the State of Delaware on September 8, 2025 to establish the designations, powers, preferences and rights of the Mandatory Convertible Preferred Stock”
Laura Francis was appointed as director at BRUKER CORP.
“appointed Laura Francis to fill the newly created vacancy on the Board, effective as of February 18, 2025.”
Thomas Bures was appointed as Chief Accounting Officer at BRUKER CORP.
“On January 13, 2025, Thomas Bures was appointed to serve as the Chief Accounting Officer of Bruker Corporation (the “Company”), effective immediately.”
Philip Ma resigned as Director at BRUKER CORP.
“On August 5, 2024, Dr. Philip Ma informed the board of directors (the “Board”) of Bruker Corporation (the “Company”) of his resignation from the Board, effective immediately, to concentrate his efforts on his own company.”
BRUKER CORP reported the first quarter ended March 31, 2024 results: revenue $721.7 million, EPS $0.35. Guidance raised.
“Bruker Reports First Quarter 2024 Financial Results • Q1 2024 revenues of $721.7 million, up 5.3% year-over-year (yoy); organic revenue up 1.6% yoy, and constant-exchange rate (CER) revenue up 5.5% yoy • Q1 2024 GAAP EPS of $0.35; non-GAAP EPS of $0.53 • Updated FY 2024 guidance: • Revenue $3.29 to $3.35 billion, up $60 million from prior guidance, implying reported growth of 11% to 13% yoy. • Organic revenue growth maintained at 5% to 7% yoy • CER revenue growth of 12% to 14% yoy, including closed Chemspeed and ELITech acquisitions, up from prior guidance of 8% to 10% yoy • Non-GAAP EPS of $2.79 to $2.84, up $0.08 from prior guidance, including ELITech EPS accretion, but excluding still pending EPS-dilutive NanoString acquisition”
BRUKER CORP entered into Asset Purchase Agreement with NanoString Technologies, Inc. valued at $392.6 million (effective 2024-04-17).
“On April 17, 2024, Bruker Corporation (the “Company”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with NanoString Technologies, Inc., a Delaware corporation (“Seller”), as the result of the Company being selected as the successful bidder in a sale authorized by the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) pursuant to, inter alia, sections 105, 363, and 365 of the United States Bankruptcy Code (the “Bankruptcy Code”).”
BRUKER CORP incurred term loan of CHF 150 million seven-year term loan facility with Bank of America, N.A. at SARON plus a margin ranging from 1.250% to 1.750% maturing seven-year.
“the Seven-Year Term Loan Agreement provides for a CHF 150 million seven-year term loan facility”
BRUKER CORP incurred term loan of CHF 150 million five-year term loan facility with Bank of America, N.A. at SARON plus a margin ranging from 1.000% to 1.500% maturing five-year.
“On March 29, 2024 (the “Effective Date”), the Company, as borrower, entered into (i) a term loan agreement with Bank of America, N.A., as administrative agent, BofA Securities, Inc., JPMorgan Chase Bank, N.A., TD Bank, N.A.”
BRUKER CORP incurred term loan of CHF 150 million three-year term loan facility with Bank of America, N.A. at SARON plus a margin ranging from 1.000% to 1.500% maturing three-year.
“The Three- and Five-Year Term Loan Agreement provides for a (i) CHF 150 million three-year term loan facility”
BRUKER CORP entered into Three- and Five-Year Term Loan Agreement with Bank of America, N.A. valued at CHF 150 million three-year term loan facility and CHF 150 million five-year term loan facility (effective 2024-04-02).
“The Three- and Five-Year Term Loan Agreement provides for a (i) CHF 150 million three-year term loan facility and (ii) CHF 150 million five-year term loan facility”
BRUKER CORP reported three months and year ended December 31, 2023 results: revenue Q4 2023 revenues of $854.5 million, EPS Q4 2023 GAAP EPS of $1.41.
“On February 13, 2024, Bruker Corporation issued a press release announcing financial results as of and for the three months and year ended December 31, 2023.”
BRUKER CORP incurred senior notes of CHF 50 million aggregate principal amount of 2.60% Series A Senior Notes due April 15, 2036 and CHF 50 million aggregate with institutional accredited investors named therein at 2.60% and 2.62% maturing April 15, 2036 and April 15, 2039.
“On February 8, 2024, Bruker Corporation (the “Company”) entered into a note purchase agreement among the Company and the institutional accredited investors named therein (the “Note Purchase Agreement”), pursuant to which the Company will issue and sell (i) CHF 50 million aggregate principal amount of 2.60% Series A Senior Notes due April 15, 2036 (the “Series A Notes”) and (ii) CHF 50 million aggregate principal amount of its 2.62% Series B Senior Notes due April 15, 2039 (the “Series B Notes” together with the Series A Notes, the “Notes”)”
BRUKER CORP entered into Note Purchase Agreement with unknown valued at Not specified in excerpt (effective 2024-02-12).
“Terms used in this Item 1.01 and not otherwise defined herein have the meanings given to them in the Note Purchase Agreement. Interest on the Notes is payable semi-annually on April 15 and October 15 of each year, commencing April 15 or October 15, 2024. The Notes are unsecured obligations of the Company and are fully and unconditionally guaranteed by certain of the Company’s subsidiaries.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.